Pulmonary Sporothrix schenckii infection in a HIV positive child

Journal of Tropical Pediatrics

Volumn 52, Issue 2, 2006, Pages 144-146

  Callens, Steven F J ^c,e   Kitetele, Faustin ^a   Lukun, Pauline ^b   Lelo, Patricia ^b   Van Rie, Annelies ^c   Behets, Frieda ^c   Colebunders, Robert ^d  

^a Kalembe Lembe Pediatric Hospital   (Congo)

^b UNIVERSITY OF KINSHASA   (Congo)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DIPYRONE; ERYTHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; GENTAMICIN; INFUSION FLUID; ISONIAZID; LAMIVUDINE; METOCLOPRAMIDE; NEVIRAPINE; PREDNISOLONE; PYRAZINAMIDE; QUININE; RIFAMPICIN; STAVUDINE; TINIDAZOLE;

ARTICLE; BLOOD CELL COUNT; CASE REPORT; CHILD; CLINICAL FEATURE; COUGHING; DIARRHEA; DRUG SUBSTITUTION; DYSPNEA; FEVER; FLUID THERAPY; GENERAL CONDITION DETERIORATION; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; LUNG INFECTION; LYMPHOCYTE COUNT; MALE; PLASMODIUM; RHINORRHEA; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

ANTIFUNGAL AGENTS; CHILD; CONGO; FLUCONAZOLE; HIV SEROPOSITIVITY; HUMANS; LUNG DISEASES; MALE; SPOROTRICHOSIS;

EID: 33645853166     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmi101     Document Type: Article

References (14)

1. da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: A study of 304 cases in Brazil. J Am Acad Dermatol 2005;52: 451-9.
2. Torrealba JR, Carvalho J, Corliss R, et al. Laryngeal granulomatous infection by Sporothrix schenckii. Otolaryngol Head Neck Surg 2005;132: 339-40.
3. Madhivanan P, Mothi SN, Kumarasamy N, et al. Clinical manifestations of HIV infected children. Indian J Pediatr 2003;70:615-20.
4. Aarestrup FM, Guerra RO, Vieira BJ, et al. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis 2001;7:134-6.
5. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis 2000;30:684-7.
6. Vismer HF, Hull PR. Prevalence, epidemiology and geographical distribution of Sporothrix schenckii infections in Gauteng, South Africa. Mycopathologia 1997;137:137-43.
7. Gumaa SA. Sporotrichosis in Sudan. Trans Roy Soc Trop Med Hyg 1978;72:637-40.
8. Mahgoub ES. Pulmonary sporotrichosis due to Sporotrichum gougerotii. J Trop Med Hyg 1968;71:313-15.
9. Marques SA, Robles AM, Tortorano AM, et al. Mycoses associated with AIDS in the Third World. Med Mycol 2000;38(Suppl 1):269-79.
10. Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS 2003;17: 1925-32.
11. Autar R, Mahanontharit A, Anekthananon T, et al. What is the clinical relevance of the drug interaction between nevirapine and rifampicin? XV International AIDS Conference. Bangkok; 2004. eJIAS. 2004 Jul 11;1:B11784
12. Ribera E, Pou L, Lopez RM, et al. Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acqu Immune Defic Syndr 2001;28:450-3.
13. Panomvana Na Ayudhya D, Thanompuangseree N, Tansuphaswadikul S. Effect of rifampicin on the pharmacokineties of fluconazole in patients with AIDS. Clin Pharmacokinet 2004;43:725-32.
14. Geel J, Pitt A, Orrell C, et al. Effect of fluconazole on nevirapine pharmacokinetics. XV International AIDS Conference. Bangkok, Thailand; 2004. eJIAS. 2004 Jul 11;1:TUPeB4606.